187 related articles for article (PubMed ID: 23840565)
21. A 43-kDa TDP-43 species is present in aggregates associated with frontotemporal lobar degeneration.
Bosque PJ; Boyer PJ; Mishra P
PLoS One; 2013; 8(5):e62301. PubMed ID: 23704877
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of TDP-43 aggregation by nucleic acid binding.
Huang YC; Lin KF; He RY; Tu PH; Koubek J; Hsu YC; Huang JJ
PLoS One; 2013; 8(5):e64002. PubMed ID: 23737961
[TBL] [Abstract][Full Text] [Related]
23. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43.
Nonaka T; Kametani F; Arai T; Akiyama H; Hasegawa M
Hum Mol Genet; 2009 Sep; 18(18):3353-64. PubMed ID: 19515851
[TBL] [Abstract][Full Text] [Related]
24. Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils.
Shimonaka S; Nonaka T; Suzuki G; Hisanaga S; Hasegawa M
J Biol Chem; 2016 Apr; 291(17):8896-907. PubMed ID: 26887947
[TBL] [Abstract][Full Text] [Related]
25. Inositol Hexakisphosphate Kinase 2 Promotes Cell Death in Cells with Cytoplasmic TDP-43 Aggregation.
Nagata E; Nonaka T; Moriya Y; Fujii N; Okada Y; Tsukamoto H; Itoh J; Okada C; Satoh T; Arai T; Hasegawa M; Takizawa S
Mol Neurobiol; 2016 Oct; 53(8):5377-83. PubMed ID: 26440668
[TBL] [Abstract][Full Text] [Related]
26. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Igaz LM; Kwong LK; Xu Y; Truax AC; Uryu K; Neumann M; Clark CM; Elman LB; Miller BL; Grossman M; McCluskey LF; Trojanowski JQ; Lee VM
Am J Pathol; 2008 Jul; 173(1):182-94. PubMed ID: 18535185
[TBL] [Abstract][Full Text] [Related]
27. SUMOylation Regulates TDP-43 Splicing Activity and Nucleocytoplasmic Distribution.
Maraschi A; Gumina V; Dragotto J; Colombrita C; Mompeán M; Buratti E; Silani V; Feligioni M; Ratti A
Mol Neurobiol; 2021 Nov; 58(11):5682-5702. PubMed ID: 34390468
[TBL] [Abstract][Full Text] [Related]
28. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
[TBL] [Abstract][Full Text] [Related]
29. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
30. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis.
Kwong LK; Uryu K; Trojanowski JQ; Lee VM
Neurosignals; 2008; 16(1):41-51. PubMed ID: 18097159
[TBL] [Abstract][Full Text] [Related]
31. Delineation of the core aggregation sequences of TDP-43 C-terminal fragment.
Saini A; Chauhan VS
Chembiochem; 2011 Nov; 12(16):2495-501. PubMed ID: 21905193
[TBL] [Abstract][Full Text] [Related]
32. TDP-43 dimerizes in human cells in culture.
Shiina Y; Arima K; Tabunoki H; Satoh J
Cell Mol Neurobiol; 2010 May; 30(4):641-52. PubMed ID: 20043239
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
[TBL] [Abstract][Full Text] [Related]
34. Asparaginyl endopeptidase cleaves TDP-43 in brain.
Herskowitz JH; Gozal YM; Duong DM; Dammer EB; Gearing M; Ye K; Lah JJ; Peng J; Levey AI; Seyfried NT
Proteomics; 2012 Aug; 12(15-16):2455-63. PubMed ID: 22718532
[TBL] [Abstract][Full Text] [Related]
35. A Computational Approach to Investigate TDP-43 RNA-Recognition Motif 2 C-Terminal Fragments Aggregation in Amyotrophic Lateral Sclerosis.
Grassmann G; Miotto M; Di Rienzo L; Salaris F; Silvestri B; Zacco E; Rosa A; Tartaglia GG; Ruocco G; Milanetti E
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944548
[TBL] [Abstract][Full Text] [Related]
36. Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region.
Budini M; Buratti E; Stuani C; Guarnaccia C; Romano V; De Conti L; Baralle FE
J Biol Chem; 2012 Mar; 287(10):7512-25. PubMed ID: 22235134
[TBL] [Abstract][Full Text] [Related]
37. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation.
Winton MJ; Igaz LM; Wong MM; Kwong LK; Trojanowski JQ; Lee VM
J Biol Chem; 2008 May; 283(19):13302-9. PubMed ID: 18305110
[TBL] [Abstract][Full Text] [Related]
38. Clinical and pathological continuum of multisystem TDP-43 proteinopathies.
Geser F; Martinez-Lage M; Robinson J; Uryu K; Neumann M; Brandmeir NJ; Xie SX; Kwong LK; Elman L; McCluskey L; Clark CM; Malunda J; Miller BL; Zimmerman EA; Qian J; Van Deerlin V; Grossman M; Lee VM; Trojanowski JQ
Arch Neurol; 2009 Feb; 66(2):180-9. PubMed ID: 19204154
[TBL] [Abstract][Full Text] [Related]
39. [Neurodegenerative disorders and TDP-43].
Nonaka T; Inukai Y; Arai T; Hasegawa M
Brain Nerve; 2009 Feb; 61(2):161-6. PubMed ID: 19235466
[TBL] [Abstract][Full Text] [Related]
40. Folliculin, a tumor suppressor associated with Birt-Hogg-Dubé (BHD) syndrome, is a novel modifier of TDP-43 cytoplasmic translocation and aggregation.
Xia Q; Wang G; Wang H; Hu Q; Ying Z
Hum Mol Genet; 2016 Jan; 25(1):83-96. PubMed ID: 26516189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]